Skip to main content
SpringerLink
Log in

Steroids

  • Chapter
  • First Online:
Autoimmune Thrombocytopenia

  • 664 Accesses

Abstract

Since the 1950s, corticosteroids, particularly prednisolone, have been key drugs in the initial treatment of immune thrombocytopenia (ITP). However, issues are associated with the long-term efficacy of prednisolone and its side effects in patients treated for a long period of time. Since the 1990s, HD-DEX has attracted attention because of its faster response, shorter treatment period, higher efficacy rate, and tolerability. A number of trials have recently been performed in order to improve the initial treatment of ITP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997;349(9064):1531–6. doi:10.1016/S0140-6736(96)12118-8.

    Article  CAS  PubMed  Google Scholar 

  2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. New Engl J Med. 2002;346(13):995–1008. doi:10.1056/NEJMra010501.

    Article  PubMed  Google Scholar 

  3. Kuwana M, Ikeda Y. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol. 2005;81(2):106–12.

    Article  CAS  PubMed  Google Scholar 

  4. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103(4):1364–9. doi:10.1182/blood-2003-08-2672.

  5. George JN, el-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. New Engl J Med. 1994;331(18):1207–11. doi:10.1056/NEJM199411033311807.

    Article  CAS  PubMed  Google Scholar 

  6. Kitchens CS, Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood. 1975;46(4):567–78.

    CAS  PubMed  Google Scholar 

  7. Kitchens CS. Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit. J Clin Invest. 1977;60(5):1129–34. doi:10.1172/JCI108864.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3–40.

    CAS  PubMed  Google Scholar 

  9. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120(4):574–96.

    Article  Google Scholar 

  10. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–86. doi:10.1182/blood-2009-06-225565.

    Article  CAS  PubMed  Google Scholar 

  11. Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–207. doi:10.1182/blood-2010-08-302984.

    Article  CAS  PubMed  Google Scholar 

  12. Fujimura K, Miyakawa Y, Kurata Y, Kuwana M, Tomiyama Y, Murata M. Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version. [Rinsho Ketsueki] Jpn J Clin Hematol. 2012;53(4):433–42.

    Google Scholar 

  13. Ben-Yehuda D, Gillis S, Eldor A. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol. 1994;91(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  14. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98(5):436–42.

    Article  CAS  PubMed  Google Scholar 

  15. von dem Borne AE, Vos JJ, Pegels JG, Thomas LL, van der L. High dose intravenous methylprednisolone or high dose intravenous gamma globulin for autoimmune thrombocytopenia. Br Med J. 1988;296(6617):249–50.

    Article  Google Scholar 

  16. Godeau B, Zini JM, Schaeffer A, Bierling P. High-dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids. Am J Hematol. 1995;48(4):282–4.

    Article  CAS  PubMed  Google Scholar 

  17. Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, et al. Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. Br J Haematol. 1998;103(4):1061–3.

    Article  CAS  PubMed  Google Scholar 

  18. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. New Engl J Med. 1994;330(22):1560–4. doi:10.1056/NEJM199406023302203.

    Article  CAS  PubMed  Google Scholar 

  19. Arruda VR, Annichino-Bizzacchi JM. High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpura. Ann Hematol. 1996;73(4):175–7.

    Article  CAS  PubMed  Google Scholar 

  20. Caulier MT, Rose C, Roussel MT, Huart C, Bauters F, Fenaux P. Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases. Br J Haematol. 1995;91(2):477–9.

    Article  CAS  PubMed  Google Scholar 

  21. Warner M, Wasi P, Couban S, Hayward C, Warkentin T, Kelton JG. Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopenia. Am J Hematol. 1997;54(4):267–70.

    Article  CAS  PubMed  Google Scholar 

  22. Stasi R, Brunetti M, Pagano A, Stipa E, Masi M, Amadori S. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Blood Cells Mol Dis. 2000;26(6):582–6. doi:10.1006/bcmd.2000.0336.

    Article  CAS  PubMed  Google Scholar 

  23. Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol. 2004;83(12):764–8. doi:10.1007/s00277-004-0908-1.

    Article  CAS  PubMed  Google Scholar 

  24. Naithani R, Mahapatra M, Kumar R, Mishra P, Saxena R. High dose dexamethasone therapy shows better responses in acute immune thrombocytopenia than in chronic immune thrombocytopenia. Platelets. 2010;21(4):270–3. doi:10.3109/09537101003637257.

    Article  CAS  PubMed  Google Scholar 

  25. Nakazaki K, Hosoi M, Hangaishi A, Ichikawa M, Nannya Y, Kurokawa M. Comparison between pulsed high-dose dexamethasone and daily corticosteroid therapy for adult primary immune thrombocytopenia: a retrospective study. Intern Med. 2012;51(8):859–63.

    Article  CAS  PubMed  Google Scholar 

  26. Sakamoto K, Nakasone H, Tsurumi S, Sasaki K, Mitani K, Kida M, et al. Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group. J Thromb Thrombolysis. 2014;37(3):279–86. doi:10.1007/s11239-013-0939-3.

    Article  CAS  PubMed  Google Scholar 

  27. Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. New Engl J Med. 2003;349(9):831–6. doi:10.1056/NEJMoa030254.

    Article  CAS  PubMed  Google Scholar 

  28. Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007;109(4):1401–7. doi:10.1182/blood-2005-12-015222.

    Article  CAS  PubMed  Google Scholar 

  29. Wei Y, Ji XB, Wang YW, Wang JX, Yang EQ, Wang ZC, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016;127(3):296–302; quiz 70. doi:10.1182/blood-2015-07-659656.

    Article  CAS  PubMed  Google Scholar 

  30. Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A, et al. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood. 2010;115(14):2755–62. doi:10.1182/blood-2009-07-229815.

    Article  CAS  PubMed  Google Scholar 

  31. Gudbrandsdottir S, Birgens HS, Frederiksen H, Jensen BA, Jensen MK, Kjeldsen L, et al. Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia. Blood. 2013;121(11):1976–81. doi:10.1182/blood-2012-09-455691.

    Article  CAS  PubMed  Google Scholar 

  32. Bussel JB, Lee CS, Seery C, Imahiyerobo AA, Thompson MV, Catellier D, et al. Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration. Haematologica. 2014;99(7):1264–71. doi:10.3324/haematol.2013.103291.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Li Z, Mou W, Lu G, Cao J, He X, Pan X, et al. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol. 2011;93(1):91–8. doi:10.1007/s12185-010-0753-z.

    Article  CAS  PubMed  Google Scholar 

  34. Gomez-Almaguer D, Tarin-Arzaga L, Moreno-Jaime B, Jaime-Perez JC, Ceballos-Lopez AA, Ruiz-Arguelles GJ, et al. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2013;90(6):494–500. doi:10.1111/ejh.12102.

    Article  CAS  PubMed  Google Scholar 

  35. Choi PY, Roncolato F, Badoux X, Ramanathan S, Ho SJ, Chong BH. A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4). Blood. 2015;126(4):500–3. doi:10.1182/blood-2015-03-631937.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Research, Hiroshima-Nishi Medical Center, Hiroshima, Japan

    Toshiro Takafuta M.D., Ph.D.

  2. Department of Nursing, Yasuda Women’s University, Hiroshima, Japan

    Kingo Fujimura M.D., Ph.D.

Authors
  1. Toshiro Takafuta M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kingo Fujimura M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiro Takafuta M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Division of Hematology and Oncology Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Iwate, Japan

    Yoji Ishida

  2. Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, Japan

    Yoshiaki Tomiyama

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Takafuta, T., Fujimura, K. (2017). Steroids. In: Ishida, Y., Tomiyama, Y. (eds) Autoimmune Thrombocytopenia　. Springer, Singapore. https://doi.org/10.1007/978-981-10-4142-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4142-6_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4141-9

  • Online ISBN: 978-981-10-4142-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation